Pharmaceutical Compositions For The Treatment Of Left Ventricular Hypertrophy And Dysfunction Associated To Metabolic Syndrome

  • Published: Jan 31, 2018
  • Earliest Priority: Jul 26 2016
  • Family: 2
  • Cited Works: 49
  • Cited by: 0
  • Cites: 0
  • Sequences: 2
  • Additional Info: Cited Works Sequence
Full-text?

The full document isn't yet available to us from the patent office.

Abstract

The present invention relates to methods and pharmaceutical compositions for the treatment of left ventricular hypertrophy and dysfunction associated to metabolic syndrome. In particular, the present invention relates to a method of treating left ventricular hypertrophy and dysfunction associated to metabolic syndrome in a subject in need thereof comprising administering to the subject a therapeutically effective amount of at least one agent capable of raising the expression of IGFBP2.


Claims

Information currently unavailable.

Download PDF
Document Preview
Document History
  • Publication: Jan 31, 2018
  • Application: Jul 26, 2016
    EP EP 16305961 A
  • Priority: Jul 26, 2016
    EP EP 16305961 A

Download Citation


Sign in to the Lens

Feedback